Cargando…
Anti-Candida Activity of Hyaluronic Acid Combined with Lactobacillus crispatus Lyophilised Supernatant: A New Antifungal Strategy
Vulvovaginal candidiasis (VVC) and recurrencies are common in reproductive-aged women. The emergence of Candida strains resistant to conventional antimycotic drugs prompted the search for alternative therapies. Hyaluronic acid (HA), a uniform and linear glycosaminoglycan, has been proposed as an ant...
Autores principales: | Parolin, Carola, Abruzzo, Angela, Giordani, Barbara, Oliver, Josidel C., Marangoni, Antonella, Luppi, Barbara, Vitali, Beatrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229037/ https://www.ncbi.nlm.nih.gov/pubmed/34070335 http://dx.doi.org/10.3390/antibiotics10060628 |
Ejemplares similares
-
Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion
por: De Gregorio, Priscilla Romina, et al.
Publicado: (2020) -
Lactobacillus crispatus BC1 Biosurfactant Counteracts the Infectivity of Chlamydia trachomatis Elementary Bodies
por: Foschi, Claudio, et al.
Publicado: (2021) -
Lactobacillus crispatus BC1 Biosurfactant Delivered by Hyalurosomes: An Advanced Strategy to Counteract Candida Biofilm
por: Abruzzo, Angela, et al.
Publicado: (2021) -
Lactobacillus crispatus BC5 Interferes With Chlamydia trachomatis Infectivity Through Integrin Modulation in Cervical Cells
por: Parolin, Carola, et al.
Publicado: (2018) -
Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study
por: Nardini, Paola, et al.
Publicado: (2016)